Orthofix Improvement Not Enough to Spur Growth

Orthofix's logo

Orthofix reported 3Q20 orthopedic revenue of USD $111 million, -2.2% vs. 3Q19. Month-to-month volumes stabilized during the quarter, but have yet to recover to normalized levels for the company. Orthofix’s spinal implant business turned in the best performance of the company’s portfolio with +19% growth in the U.S., driven by $5.2 million in...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Mike Evers is a Senior Market Analyst and writer with over 15 years of experience in the medical industry, spanning cardiac rhythm management, ER coding and billing, and orthopedics. He joined ORTHOWORLD in 2018, where he provides market analysis and editorial coverage.

Contact Us